Citizens Financial Group Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Citizens Financial Group Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities | ||||||||||||||||||||||
net income | 436,000,000 | 373,000,000 | 401,000,000 | 382,000,000 | 392,000,000 | 334,000,000 | 189,000,000 | 430,000,000 | 478,000,000 | 511,000,000 | 653,000,000 | 636,000,000 | 364,000,000 | 420,000,000 | 530,000,000 | 530,000,000 | 648,000,000 | 611,000,000 | 456,000,000 | 314,000,000 | 253,000,000 | 34,000,000 |
adjustments to reconcile net income to net change due to operating activities: | ||||||||||||||||||||||
benefit for credit losses | 164,000,000 | 153,000,000 | 162,000,000 | 172,000,000 | 182,000,000 | 171,000,000 | 171,000,000 | 172,000,000 | 176,000,000 | 168,000,000 | 132,000,000 | 123,000,000 | 216,000,000 | 3,000,000 | ||||||||
net change in loans held for sale | 35,000,000 | -332,000,000 | -370,000,000 | -81,000,000 | 329,000,000 | 184,000,000 | 322,000,000 | 898,000,000 | 462,000,000 | 301,000,000 | 944,000,000 | -622,000,000 | ||||||||||
depreciation, amortization, and accretion | ||||||||||||||||||||||
deferred income tax expense | -99,000,000 | -16,000,000 | -127,000,000 | -18,000,000 | -181,000,000 | -21,000,000 | ||||||||||||||||
share-based compensation | 43,000,000 | 31,000,000 | 21,000,000 | 21,000,000 | 21,000,000 | 34,000,000 | 14,000,000 | 18,000,000 | 22,000,000 | 33,000,000 | 16,000,000 | 16,000,000 | 19,000,000 | 33,000,000 | 12,000,000 | 12,000,000 | 13,000,000 | 22,000,000 | 14,000,000 | 11,000,000 | 2,000,000 | 21,000,000 |
net gain on sale of assets | -5,000,000 | -9,000,000 | -4,000,000 | -9,000,000 | 0 | -5,000,000 | ||||||||||||||||
net increase in other assets | 325,000,000 | 34,000,000 | -247,000,000 | -291,000,000 | 324,000,000 | -47,000,000 | 1,344,000,000 | 95,000,000 | -455,000,000 | -372,000,000 | -194,000,000 | 1,645,000,000 | -2,129,000,000 | -1,216,000,000 | 674,000,000 | -264,000,000 | ||||||
net increase in other liabilities | -137,000,000 | -570,000,000 | 239,000,000 | -233,000,000 | -110,000,000 | -206,000,000 | -1,057,000,000 | -279,000,000 | 148,000,000 | 849,000,000 | 459,000,000 | 229,000,000 | -1,052,000,000 | 1,400,000,000 | -76,000,000 | 586,000,000 | ||||||
net change due to operating activities | 886,000,000 | -213,000,000 | 483,000,000 | 130,000,000 | 834,000,000 | 554,000,000 | 670,000,000 | 1,008,000,000 | 125,000,000 | 1,158,000,000 | 1,441,000,000 | 3,000,000,000 | -1,876,000,000 | 1,554,000,000 | 1,105,000,000 | 1,280,000,000 | ||||||
investing activities | ||||||||||||||||||||||
investment securities: | ||||||||||||||||||||||
purchases of debt securities available for sale | -1,760,000,000 | -2,365,000,000 | -3,258,000,000 | -2,010,000,000 | -1,430,000,000 | -3,057,000,000 | -4,511,000,000 | -2,370,000,000 | -1,983,000,000 | -1,223,000,000 | -1,004,000,000 | -1,134,000,000 | -5,982,000,000 | -2,656,000,000 | -3,737,000,000 | -2,256,000,000 | -2,157,000,000 | -4,256,000,000 | ||||
proceeds from maturities and paydowns of debt securities available for sale | 963,000,000 | 846,000,000 | 1,192,000,000 | 794,000,000 | 725,000,000 | 593,000,000 | 520,000,000 | 552,000,000 | 506,000,000 | 423,000,000 | 579,000,000 | 679,000,000 | 961,000,000 | 1,203,000,000 | 1,751,000,000 | 1,738,000,000 | 2,040,000,000 | 2,281,000,000 | 2,360,000,000 | 2,062,000,000 | 1,511,000,000 | 1,010,000,000 |
proceeds from sales of debt securities available for sale | 475,000,000 | 642,000,000 | 1,539,000,000 | 1,377,000,000 | 11,000,000 | 692,000,000 | 512,000,000 | 797,000,000 | 237,000,000 | 1,395,000,000 | 121,000,000 | 0 | 353,000,000 | 704,000,000 | 632,000,000 | 54,000,000 | 50,000,000 | 54,000,000 | 537,000,000 | |||
proceeds from maturities and paydowns of debt securities held to maturity | 198,000,000 | 150,000,000 | 161,000,000 | 177,000,000 | 174,000,000 | 150,000,000 | 164,000,000 | 228,000,000 | 187,000,000 | 182,000,000 | 263,000,000 | 270,000,000 | 312,000,000 | 190,000,000 | 254,000,000 | 222,000,000 | 289,000,000 | 241,000,000 | 268,000,000 | 280,000,000 | 218,000,000 | 131,000,000 |
net increase in interest-bearing deposits in banks | 5,000,000 | -50,000,000 | 13,000,000 | -89,000,000 | -167,000,000 | 13,000,000 | -81,000,000 | -40,000,000 | 36,000,000 | -17,000,000 | -42,000,000 | 208,000,000 | 216,000,000 | -369,000,000 | -27,000,000 | 112,000,000 | -93,000,000 | -2,000,000 | ||||
purchases of loans | -315,000,000 | -188,000,000 | -138,000,000 | -77,000,000 | -95,000,000 | -345,000,000 | 0 | -28,000,000 | -261,000,000 | -718,000,000 | ||||||||||||
sales of loans | 671,000,000 | 240,000,000 | 21,000,000 | 61,000,000 | 18,000,000 | 107,000,000 | 165,000,000 | 293,000,000 | 2,020,000,000 | 315,000,000 | 959,000,000 | 1,301,000,000 | 112,000,000 | 305,000,000 | ||||||||
net increase in loans and leases | -1,502,000,000 | -319,000,000 | 2,190,000,000 | 29,000,000 | 958,000,000 | 2,873,000,000 | 3,384,000,000 | 1,131,000,000 | 1,963,000,000 | 696,000,000 | -990,000,000 | -322,000,000 | -4,419,000,000 | -2,196,000,000 | -2,793,000,000 | -881,000,000 | ||||||
capital expenditures | -33,000,000 | -14,000,000 | -48,000,000 | -34,000,000 | -30,000,000 | -10,000,000 | -48,000,000 | -33,000,000 | -39,000,000 | -52,000,000 | 15,000,000 | -85,000,000 | -5,000,000 | -51,000,000 | -65,000,000 | -27,000,000 | -22,000,000 | -10,000,000 | -119,000,000 | |||
free cash flows | -700,000,000 | |||||||||||||||||||||
other | -130,000,000 | -50,000,000 | -64,000,000 | -67,000,000 | 15,000,000 | 23,000,000 | 120,000,000 | -176,000,000 | 222,000,000 | -227,000,000 | -39,000,000 | -5,000,000 | -644,000,000 | -83,000,000 | -119,000,000 | -82,000,000 | -68,000,000 | -47,000,000 | ||||
net change due to investing activities | -1,428,000,000 | -1,108,000,000 | 1,608,000,000 | 161,000,000 | 179,000,000 | 1,039,000,000 | 225,000,000 | 382,000,000 | 3,149,000,000 | 1,492,000,000 | -158,000,000 | 883,000,000 | -9,448,000,000 | -3,914,000,000 | -7,499,000,000 | -1,284,000,000 | ||||||
financing activities | ||||||||||||||||||||||
net increase in deposits | -2,490,000,000 | 2,800,000,000 | -412,000,000 | -1,164,000,000 | -76,000,000 | -914,000,000 | -855,000,000 | 530,000,000 | 5,473,000,000 | -8,530,000,000 | 2,158,000,000 | -359,000,000 | -68,000,000 | 4,415,000,000 | 2,140,000,000 | 1,585,000,000 | -713,000,000 | 4,185,000,000 | -697,000,000 | 10,143,000,000 | 8,162,000,000 | |
net increase in short-term borrowed funds | 202,000,000 | 47,000,000 | -15,000,000 | 13,000,000 | -7,000,000 | -496,000,000 | 273,000,000 | -867,000,000 | 81,000,000 | 1,015,000,000 | -269,000,000 | -3,500,000,000 | 3,726,000,000 | -52,000,000 | 86,000,000 | -57,000,000 | -7,000,000 | -176,000,000 | 780,000,000 | |||
proceeds from issuance of long-term borrowed funds | 3,500,000,000 | 2,533,000,000 | 0 | 2,332,000,000 | 5,088,000,000 | 5,765,000,000 | 4,750,000,000 | 9,016,000,000 | 6,507,000,000 | 5,710,000,000 | 13,101,000,000 | 6,299,000,000 | 14,000,000 | 1,509,000,000 | 6,800,000,000 | |||||||
repayments of long-term borrowed funds | -3,251,000,000 | -2,675,000,000 | -1,545,000,000 | -1,485,000,000 | -5,819,000,000 | -5,437,000,000 | -8,652,000,000 | -5,762,000,000 | -11,252,000,000 | -2,752,000,000 | -13,501,000,000 | -4,434,000,000 | -752,000,000 | -1,004,000,000 | 4,000,000 | 1,000,000 | -1,353,000,000 | -4,000,000 | ||||
treasury stock purchased | -200,000,000 | -200,000,000 | -225,000,000 | -325,000,000 | -200,000,000 | -300,000,000 | 0 | -151,000,000 | 0 | -200,000,000 | 0 | 0 | -95,000,000 | |||||||||
net proceeds from issuance of preferred stock | 1,000,000 | 0 | 0 | 0 | 0 | |||||||||||||||||
dividends paid to common stockholders | -185,000,000 | -186,000,000 | -188,000,000 | -190,000,000 | -194,000,000 | -197,000,000 | -199,000,000 | -199,000,000 | -205,000,000 | -205,000,000 | -167,000,000 | -168,000,000 | -167,000,000 | |||||||||
dividends paid to preferred stockholders | -33,000,000 | -34,000,000 | -38,000,000 | -35,000,000 | -30,000,000 | -31,000,000 | -31,000,000 | -32,000,000 | -24,000,000 | -33,000,000 | -33,000,000 | -23,000,000 | -32,000,000 | |||||||||
net change due to financing activities | -2,451,000,000 | 2,261,000,000 | -2,405,000,000 | -1,147,000,000 | -841,000,000 | -1,622,000,000 | -4,667,000,000 | 2,443,000,000 | 319,000,000 | -5,223,000,000 | 1,104,000,000 | -2,237,000,000 | 7,902,000,000 | 3,138,000,000 | 1,836,000,000 | 1,079,000,000 | ||||||
net change in cash and cash equivalents | -2,993,000,000 | 940,000,000 | -314,000,000 | -856,000,000 | 172,000,000 | -29,000,000 | -3,772,000,000 | 3,833,000,000 | 3,593,000,000 | -2,573,000,000 | 2,387,000,000 | 1,646,000,000 | -3,422,000,000 | 778,000,000 | -4,558,000,000 | 1,075,000,000 | ||||||
cash and cash equivalents at beginning of period | 0 | 10,601,000,000 | 0 | 0 | 0 | 11,628,000,000 | 0 | 0 | 0 | 10,547,000,000 | 0 | 0 | 0 | 9,158,000,000 | 0 | 0 | 0 | 12,733,000,000 | 0 | 0 | 3,386,000,000 | |
cash and cash equivalents at end of period | -2,993,000,000 | 11,541,000,000 | -314,000,000 | -856,000,000 | 172,000,000 | 11,599,000,000 | -3,772,000,000 | 3,833,000,000 | 3,593,000,000 | 7,974,000,000 | 2,387,000,000 | 1,646,000,000 | -3,422,000,000 | 9,936,000,000 | -4,558,000,000 | 1,075,000,000 | -2,019,000,000 | 14,660,000,000 | 1,770,000,000 | 3,388,000,000 | 4,058,000,000 | |
non-cash items: | ||||||||||||||||||||||
transfer of loans from loans held for investment to lhfs | 42,000,000 | 1,876,000,000 | ||||||||||||||||||||
loans securitized and transferred to afs securities | 48,000,000 | |||||||||||||||||||||
depreciation, amortization and accretion | 123,000,000 | 124,000,000 | 129,000,000 | 143,000,000 | 102,000,000 | 126,000,000 | 122,000,000 | 112,000,000 | 118,000,000 | 117,000,000 | 121,000,000 | 260,000,000 | 67,000,000 | 172,000,000 | 136,000,000 | 165,000,000 | 152,000,000 | 154,000,000 | 103,000,000 | 109,000,000 | 201,000,000 | |
acquisitions, net of cash acquired | -20,000,000 | -1,000,000 | -91,000,000 | -143,000,000 | -151,000,000 | |||||||||||||||||
purchases of bank-owned life insurance | ||||||||||||||||||||||
redemption of preferred stock | 0 | 0 | ||||||||||||||||||||
net change in loans held for sale, at fair value | -23,000,000 | -86,000,000 | 171,000,000 | 73,000,000 | ||||||||||||||||||
transfer of loans from loans held for investment to loans held for sale | 34,000,000 | 108,000,000 | 107,000,000 | |||||||||||||||||||
adjustments to reconcile net income to net change in cash due to operating activities: | ||||||||||||||||||||||
premium paid to exchange debt | ||||||||||||||||||||||
net gain on sales of assets | -5,000,000 | -9,000,000 | -5,000,000 | 0 | -1,000,000 | -4,000,000 | ||||||||||||||||
purchase of bank-owned life insurance | 0 | 0 | -100,000,000 | -150,000,000 | -125,000,000 | -375,000,000 | ||||||||||||||||
payments of employee tax withholding for share-based compensation | 0 | -2,000,000 | -24,000,000 | -1,000,000 | 0 | -1,000,000 | -23,000,000 | -1,000,000 | 0 | 0 | -21,000,000 | |||||||||||
transfer of loans from portfolio to lhfs | 181,000,000 | |||||||||||||||||||||
transfer of securities from available for sale to held to maturity | 753,000,000 | |||||||||||||||||||||
investors acquisition: | ||||||||||||||||||||||
fair value of assets acquired, excluding cash and cash equivalents | -69,000,000 | |||||||||||||||||||||
goodwill and other intangible assets | 78,000,000 | |||||||||||||||||||||
fair value of liabilities assumed | 9,000,000 | |||||||||||||||||||||
common stock issued | 0 | |||||||||||||||||||||
replacement equity awards | 0 | |||||||||||||||||||||
treasury stock purchased, including excise tax | -259,000,000 | -404,000,000 | ||||||||||||||||||||
deferred income taxes | -63,000,000 | -67,000,000 | 46,000,000 | 125,000,000 | -47,000,000 | -643,000,000 | 15,000,000 | 119,000,000 | 80,000,000 | |||||||||||||
dividends declared and paid to common stockholders | -210,000,000 | -209,000,000 | -195,000,000 | -165,000,000 | ||||||||||||||||||
dividends declared and paid to preferred stockholders | -23,000,000 | -34,000,000 | -23,000,000 | -33,000,000 | ||||||||||||||||||
benefit from credit losses | -25,000,000 | -33,000,000 | -213,000,000 | -140,000,000 | 124,000,000 | 428,000,000 | 464,000,000 | 600,000,000 | ||||||||||||||
supplemental disclosures: | ||||||||||||||||||||||
interest paid | ||||||||||||||||||||||
income taxes paid | ||||||||||||||||||||||
transfer of securities from held to maturity to available for sale | ||||||||||||||||||||||
loans securitized and transferred to securities available for sale | ||||||||||||||||||||||
loans securitized and transferred to securities held to maturity | ||||||||||||||||||||||
stock issued for share-based compensation plans | ||||||||||||||||||||||
stock issued for employee stock purchase plan | ||||||||||||||||||||||
net gain on sales of: | ||||||||||||||||||||||
debt securities | -3,000,000 | |||||||||||||||||||||
premises and equipment | 0 | |||||||||||||||||||||
premium paid to exchange subordinated debt | 0 | 0 | -1,000,000 | |||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||
net gain on sale of debt securities | -3,000,000 | |||||||||||||||||||||
increase in other assets | -773,000,000 | |||||||||||||||||||||
decrease in other liabilities | -17,000,000 | |||||||||||||||||||||
net cash from operating activities | -690,000,000 | |||||||||||||||||||||
net decrease (increase) in loans and leases | 1,042,000,000 | |||||||||||||||||||||
net cash from investing activities | -1,072,000,000 | |||||||||||||||||||||
net cash from financing activities | 3,689,000,000 | -988,000,000 | 2,305,000,000 | 10,767,000,000 | ||||||||||||||||||
increase in cash and cash equivalents | 1,927,000,000 | 1,770,000,000 | 3,388,000,000 | 672,000,000 | ||||||||||||||||||
amortization of intangibles | 5,000,000 | 0 | 3,000,000 | 3,000,000 | ||||||||||||||||||
increase in other liabilities | 432,000,000 | 270,000,000 | ||||||||||||||||||||
net decrease in equity securities, at fair value | ||||||||||||||||||||||
net decrease in equity securities, at cost | 2,000,000 | |||||||||||||||||||||
net decrease in short-term borrowed funds | ||||||||||||||||||||||
net increase in equity securities, at fair value | ||||||||||||||||||||||
net increase in equity securities, at cost | ||||||||||||||||||||||
net decrease (increase) in interest-bearing deposits in banks | 17,000,000 | |||||||||||||||||||||
originations of mortgage loans held for sale | ||||||||||||||||||||||
proceeds from sales of mortgage loans held for sale | ||||||||||||||||||||||
purchases of commercial loans held for sale | ||||||||||||||||||||||
proceeds from sales of commercial loans held for sale | ||||||||||||||||||||||
mortgage servicing rights valuation charge-off | ||||||||||||||||||||||
debt securities impairment | ||||||||||||||||||||||
equity securities | ||||||||||||||||||||||
other loans held for sale | ||||||||||||||||||||||
purchases of securities available for sale | ||||||||||||||||||||||
purchases of debt securities held to maturity | ||||||||||||||||||||||
purchases of equity securities, at fair value | ||||||||||||||||||||||
proceeds from sales of equity securities, at fair value | ||||||||||||||||||||||
purchases of equity securities, at cost | ||||||||||||||||||||||
proceeds from sales of equity securities, at cost | ||||||||||||||||||||||
purchases of mortgage servicing rights | ||||||||||||||||||||||
net increase in bank-owned life insurance | ||||||||||||||||||||||
premises and equipment: | ||||||||||||||||||||||
purchases | ||||||||||||||||||||||
proceeds from sales | ||||||||||||||||||||||
capitalization of software | ||||||||||||||||||||||
net decrease in federal funds purchased and securities sold under agreements to repurchase | ||||||||||||||||||||||
net increase in other short-term borrowed funds |
We provide you with 20 years of cash flow statements for Citizens Financial Group stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Citizens Financial Group stock. Explore the full financial landscape of Citizens Financial Group stock with our expertly curated income statements.
The information provided in this report about Citizens Financial Group stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.